Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saxagliptin Add-on to Premixed Insulin in Elderly T2DM
ChiCTR-IPR-17010318Phase 4Recruiting
- Sponsor
- Peking University Shougang Hospital
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of saxagliptin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Peking University Shougang Hospital. Primary endpoints: Pancreatic function, Lipids and 1 more. Started Jan 2017; status: recruiting.
02
Drugs
saxagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR-IPR-17010318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17010318.